digestive/alimentary system
|
• abnormal mucus secretion compared with wild-type mice
|
|
• decreased fecal pH
• in the feces, mice exhibited a higher abundance of operational taxonomic units in the genera Pseudomonas, Fimbriimonadaceae, OLB12, and a reduction in Escherichia-Shigella and Candidatus-Kuenenia compared with wild-type mice
|
|
• fragile intestinal tissue
• damaged intercellular junctions among intestinal epithelial cells with irregular distribution of microvilli
|
|
• in the small intestines and colons
|
|
• with fewer and smaller granules
|
|
• in the feces, mice exhibited a higher abundance of operational taxonomic units in the genera Pseudomonas, Fimbriimonadaceae, OLB12, and a reduction in Escherichia-Shigella and Candidatus-Kuenenia compared with wild-type mice
|
|
• impaired autophagy
|
|
• DSS-treated mice exhibit increased inflammation compared with similarly treated wild-type mice
|
growth/size/body
immune system
|
• inflammation in the liver, lung, brain, kidney, and pancreas
|
|
• DSS-treated mice exhibit increased inflammation compared with similarly treated wild-type mice
|
renal/urinary system
nervous system
liver/biliary system
respiratory system
integument
|
• unkempt fur
|
endocrine/exocrine glands
|
• with fewer and smaller granules
|
cellular
|
• in the small intestines and colons
|
|
• abnormal mucus secretion compared with wild-type mice
|


Analysis Tools